Dyslipidaemia, statins and rheumatoid arthritis
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data
Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study
Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)
Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional study
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
Sex differences in the association between body mass index and total hip or knee joint replacement resulting from osteoarthritis
Validity of the polymyalgia rheumatica activity score in primary care practice
Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis
Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis
High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients
Differential upregulation of the three transforming growth factor beta isoforms in human osteoarthritic cartilage
Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6
Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis
The −670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis
New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA
Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis
Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts
The effect of joint position on Doppler flow in finger synovitis
Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus
Severe bronchospasm associated with rituximab for refractory Churg–Strauss syndrome
Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis
Corrections
Corrections